These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6163171)

  • 21. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ; Manji HK
    Arch Gen Psychiatry; 1993 Aug; 50(8):653-6. PubMed ID: 7688211
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurotransmitter-related enzymes in the major psychiatric disorders: I. Catechol-O-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities.
    Murphy DL; Wyatt RJ
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():277-88. PubMed ID: 769115
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoamine oxidase (MAO), 5-hydroxyindole acetic acid (5 HIAA) and homovanillic acid (HVA) in motor neuron disease.
    Forsgren L; Almay BG; Häggendal J; Oreland L
    Acta Neurol Scand; 1987 Jan; 75(1):22-7. PubMed ID: 2437756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of monoamine oxidase and catechol orthomethyltransferase activity of the thrombocytes of healthy subjects of various age groups].
    Mezhkulova NK; Petunin SN
    Fiziol Cheloveka; 1986; 12(2):316-21. PubMed ID: 3699377
    [No Abstract]   [Full Text] [Related]  

  • 26. Understanding biochemical pathology of depressive illness. An overview.
    Jain M; Jain KM
    Psychiatr Neurol Neurochir; 1973; 76(4):285-95. PubMed ID: 4354410
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

  • 28. Affective disorders: biological aspects.
    Ban TA
    Acta Neurol (Napoli); 1985 Apr; 7(2):129-34. PubMed ID: 2409751
    [No Abstract]   [Full Text] [Related]  

  • 29. Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?
    Csernansky JG; Faull KF; Pfefferbaum A
    Psychiatry Res; 1988 Sep; 25(3):361-3. PubMed ID: 2460883
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biological aspects of suicide].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1983; 83(1):7-12. PubMed ID: 6193681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of monoamine oxidase and catechol-O-methyltransferase in human blood components: methodical aspects (author's transl)].
    Christ W; Rakow D; Honecker H; Coper H
    Arzneimittelforschung; 1976; 26(6):1151-2. PubMed ID: 989404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentrations of cerebrospinal fluid monoamine metabolites in suicides.
    Lester D
    Psychol Rep; 1991 Feb; 68(1):146. PubMed ID: 1709746
    [No Abstract]   [Full Text] [Related]  

  • 33. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L; Asberg M; Lantto O; Scalia-Tomba GP; Träskman-Bendz L; Tybring G
    Psychiatry Res; 1982 Feb; 6(1):77-83. PubMed ID: 6173891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebrospinal fluid monoamine metabolites and atmospheric pressure.
    Heilig M; Månsson JE; Blennow K
    Biol Psychiatry; 1996 Feb; 39(4):299-301. PubMed ID: 8645778
    [No Abstract]   [Full Text] [Related]  

  • 36. Depression and Parkinson's disease.
    Mayeux R; Stern Y; Williams JB; Sano M; Cote L
    Adv Neurol; 1987; 45():451-5. PubMed ID: 2435113
    [No Abstract]   [Full Text] [Related]  

  • 37. MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia.
    Van Kammen DP; Marder SR; Murphy DL; Bunney WE
    Am J Psychiatry; 1978 May; 135(5):567-9. PubMed ID: 645949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
    Jibson M; Faull KF; Csernansky JG
    Biol Psychiatry; 1990 Oct; 28(7):595-602. PubMed ID: 1699614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
    Bryer JB; Starkstein SE; Votypka V; Parikh RM; Price TR; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):440-2. PubMed ID: 1384852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.